A SCID-hu in vivo model of human Waldenström macroglobulinemia. - Wikidata - wikimedia - TriplyDB

A SCID-hu in vivo model of human Waldenström macroglobulinemia.

A SCID-hu in vivo model of human Waldenström macroglobulinemia.

http://www.wikidata.org/entity/Q42742542

about

MicroRNAs in multiple myeloma and related bone disease In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma Novel therapeutic strategies targeting growth factor signalling cascades in multiple myeloma.CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia.Navigating the bone marrow niche: translational insights and cancer-driven dysfunction.Mouse models as a translational platform for the development of new therapeutic agents in multiple myeloma.Molecular pathogenesis of Waldenstrom's macroglobulinemia.The bone marrow microenvironment in waldenstrom macroglobulinemia.Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma.Emerging pathways as individualized therapeutic target of multiple myeloma.Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities.miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies.A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.Mouse models of multiple myeloma: technologic platforms and perspectives.

P2860

Q26770478-AEA0A4F4-179F-4706-81F6-589EA9B94740 Q35108549-1CCA9ADE-CC31-4A76-A354-0B384A6125FA Q36367811-0E1AB825-BE03-4C00-B6FA-CA5A9364DF43 Q37001989-65894BAE-549B-4A2E-B556-B2CA847E9E2F Q37101382-1E611F76-6815-4EC3-B6AE-9B66033093F8 Q38016511-04220A9A-1E93-44BD-AA65-2102177E64E4 Q38024773-9FB54B0D-E7C0-4426-9B56-8BE1CF7052FD Q38095959-370F4740-2C89-42F5-B794-A24E79AED6D1 Q38108387-2F2210E1-A7DC-4453-AD32-2F98A89C8411 Q38112176-F3C88B01-F7A7-4FE6-8AFC-83B3A9DDC929 Q38150849-2CE9C6E1-1E01-41E9-AC2C-27C9A71BF319 Q38299932-259C3C2E-FF50-45A3-A276-5755DEC95CE5 Q38476564-8072BE9F-1A1F-4613-A720-EDB93AAB8BF9 Q51735874-5E8E0462-E309-47DC-810D-B657528235AB Q55038802-2FD6350D-E064-4A5E-8ED2-5856459D7A2D

P2860

A SCID-hu in vivo model of human Waldenström macroglobulinemia.

http://www.wikidata.org/entity/Q42742542

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

A SCID-hu in vivo model of human Waldenström macroglobulinemia.

@en

A SCID-hu in vivo model of human Waldenström macroglobulinemia.

@nl

type

label

A SCID-hu in vivo model of human Waldenström macroglobulinemia.

@en

A SCID-hu in vivo model of human Waldenström macroglobulinemia.

@nl

prefLabel

A SCID-hu in vivo model of human Waldenström macroglobulinemia.

@en

A SCID-hu in vivo model of human Waldenström macroglobulinemia.

@nl

P1433

Q42742542-C7DEF69E-FF17-4B92-9411-57EED71EE726

P1476

Q42742542-2DC7FEB4-7DB3-4D58-AE6E-126F53A1533A

P2093

Q42742542-0C96B359-F72A-4AB4-BBD1-0F96106B7A55

Q42742542-1D1447FE-0A77-41A2-8391-78ABE63669CD

Q42742542-302BD12D-2C5D-4746-8F7A-567D1F87125E

Q42742542-823E33BA-317B-46B1-8E88-39F58A5B5884

Q42742542-B436421D-E840-4A9C-811C-E3C75C32E1DA

Q42742542-B6A2B16F-E86E-42C1-96F2-C46A25FA991C

Q42742542-DB62BE8A-DB56-4874-AD5A-C03BF78F24BE

Q42742542-DCE487CF-F527-47F7-A582-F997B49306E0

Q42742542-EAE75CC6-A2E8-4208-9729-B9CD4E62EB6F

Q42742542-F45E1DF1-99D6-4F67-AED0-B89065F35C66

P2860

Q42742542-1805133B-2C80-4DC1-8EBF-41C45435C910

Q42742542-3E6A36A9-677B-4B10-ACE6-249CC6A5475C

Q42742542-47ADB363-AAA9-4926-A3D8-363A72DC11A3

Q42742542-49D5AC84-F70F-4C87-98A9-5A64B89EF0C9

Q42742542-62B8D5A0-549A-42FA-B89C-19B294683480

Q42742542-738F3085-8CF1-4EFD-A321-8F60125EF8AC

Q42742542-771708FD-2C29-4CA5-82C1-AAD7FF74B185

Q42742542-7844E90E-5DDB-4494-92C2-C06FC0DB80FA

Q42742542-81726088-CDBF-48AE-8A45-780222373FB8

Q42742542-830DF27B-D004-4598-A8C8-C121193F5C70

P304

Q42742542-1C282122-6A32-438D-BE5F-8B21DF5E4FE7

P31

Q42742542-1346A24F-9F3E-44CF-8C6D-816A0017388B

P356

Q42742542-299A61FB-3B2C-459A-BC9C-F9F553F0BA20

P407

Q42742542-84E86EE7-CD0C-4704-B3FA-59D6D8ABFB9E

P433

Q42742542-473D6CDE-9F98-441C-AC9C-CC9989319C7E

P478

Q42742542-6951B8C5-23E8-4DE3-A2B9-CB7EAB0F82C5

P50

Q42742542-8FC6ACF3-153F-4BE8-8993-8B266FEDC9A1

P577

Q42742542-55734F49-D3E0-441B-8330-91784FCBE4D9

P5875

Q42742542-949FB33B-8720-438A-8665-83FE48B52556

P698

Q42742542-0B350AA2-C7EA-4ABF-BD40-7F1B54298FC1

P932

Q42742542-C183FD20-DCD8-46E5-869D-9693566AE454

P356

BLOOD-2004-11-4477

P1433

P1476

A SCID-hu in vivo model of human Waldenström macroglobulinemia.

@en

P2093

Daniel Ditzel Santos

http://www.w3.org/2001/XMLSchema#string

Evdoxia Hatjiharissi

http://www.w3.org/2001/XMLSchema#string

Jeffery L Kutok

http://www.w3.org/2001/XMLSchema#string

Nikhil C Munshi

http://www.w3.org/2001/XMLSchema#string

Olivier Tournilhac

http://www.w3.org/2001/XMLSchema#string

Paola Neri

http://www.w3.org/2001/XMLSchema#string

Pierfrancesco Tassone

http://www.w3.org/2001/XMLSchema#string

Salvatore Venuta

http://www.w3.org/2001/XMLSchema#string

Steven P Treon

http://www.w3.org/2001/XMLSchema#string

Vidit Munshi

http://www.w3.org/2001/XMLSchema#string

P2860

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group

The use of rituximab in the treatment of malignant and nonmalignant plasma cell disorders.

Targeted therapy for multiple myeloma.

Molecular mechanisms of novel therapeutic approaches for multiple myeloma.

Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Waldenström macroglobulinaemia.

In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cells.

Treatment of Waldenström's macroglobulinemia with rituximab.

Moving disease biology from the lab to the clinic.

The Wayne State University Waldenstrom's Macroglobulinemia preclinical model for Waldenstrom's macroglobulinemia.

P304

1341-1345

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2004-11-4477

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

Kenneth C Anderson

P577

2005-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7855457

http://www.w3.org/2001/XMLSchema#string

P698

15886318

http://www.w3.org/2001/XMLSchema#string

P932

1895190

http://www.w3.org/2001/XMLSchema#string